Université Paris Cité, AP-HP, Lariboisière-Fernand Widal Hospital, Department of Physical Medicine and Rehabilitation, Paris, France; Université Paris Cité, INSERM U1153, Epidemiology of Ageing and Neurodegenerative Diseases (EpiAgeing), Paris, France; Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, ISCIII, Dr. Antoni Pujadas, 42, Sant Boi de Llobregat, Barcelona 08830, Spain.
Université Paris Cité, AP-HP, Lariboisière-Fernand Widal Hospital, Department of Rheumatology, Paris, France.
Ann Phys Rehabil Med. 2024 Sep;67(6):101852. doi: 10.1016/j.rehab.2024.101852. Epub 2024 Jun 1.
There are several therapeutic options for the management of shoulder adhesive capsulitis (AC). The superiority of arthro-distension over intra-articular steroid injection (ISI) for AC remains controversial.
To evaluate the efficacy of a single arthro-distension procedure combined with early and intensive mobilization (ADM) and physiotherapy, versus ISI and physiotherapy, in people with AC lasting ≥3 months.
This was a prospective, 2 parallel-group, 2-center, observer-blind randomized controlled trial conducted in tertiary care settings. Adults with AC were randomly assigned to the treatment or control group. Efficacy was assessed using the self-administered Shoulder Pain and Disability Index (SPADI). Total, pain and disability SPADI scores 15 days, 6 weeks, and 3, 6 and 12 months after the procedure (total SPADI at 15 days: primary outcome; other outcomes were secondary) were compared between groups using analysis of covariance (ANCOVA). A post hoc analysis stratified on the initial range of passive glenohumeral abduction, which had not been pre-specified, was conducted.
There were 33 participants in each group. Both groups improved over time. Mean (SD) total SPADI score at 15 days was 33.8 (19.6) in the treatment group and 32.8 (17.5) in the control group, p = 0.393. There were no significant differences for any variables in the overall sample. The post hoc analysis found ADM to be associated with a significant decrease in total SPADI score at 15 days compared with ISI (p = 0.049) in individuals with initial passive glenohumeral abduction >45°.
The effects of ADM on pain and function were not statistically different from those of ISI. However, ADM may be useful in individuals with initial passive glenohumeral abduction >45°.
NCT00724113.
治疗肩粘连性囊炎(AC)有几种治疗选择。关节扩张术优于关节内类固醇注射(ISI)治疗 AC 的优势仍存在争议。
评估单次关节扩张术联合早期和强化运动(ADM)和物理治疗与 ISI 和物理治疗在持续时间≥3 个月的 AC 患者中的疗效。
这是一项前瞻性、2 平行组、2 中心、观察者盲随机对照试验,在三级护理环境中进行。将 AC 成人随机分配到治疗组或对照组。使用自我管理的肩部疼痛和残疾指数(SPADI)评估疗效。在治疗后 15 天、6 周、3、6 和 12 个月时,使用协方差分析(ANCOVA)比较两组之间的总、疼痛和残疾 SPADI 评分(治疗后 15 天的总 SPADI:主要结果;其他结果为次要结果)。未预先指定的初始被动肩肱关节外展范围进行了分层的事后分析。
每组各有 33 名参与者。两组在治疗后均有所改善。治疗组总 SPADI 评分为 33.8(19.6),对照组为 32.8(17.5),p = 0.393。在总体样本中,任何变量均无显著差异。事后分析发现,与 ISI 相比,ADM 与初始被动肩肱关节外展>45°的个体在 15 天时总 SPADI 评分显著降低相关(p = 0.049)。
ADM 对疼痛和功能的影响在统计学上与 ISI 无差异。然而,ADM 可能对初始被动肩肱关节外展>45°的个体有用。
NCT00724113。